Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q3 2018 call → NOWe need to answer YES or NO based on the transcript. The question asks: does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup — that is, does management describe current activity, demand, or commitments arriving at a scale that is large relative to how small the company still is, so that the reported results look like the early portion of something meaningfully bigger rather than a full picture of the business? We need to find if management's own words convey a disproportion between the size of the company and the size of what is currently arriving or being committed to it, grounded in real, present-tense business. Look for statements about current activity, orders, customers, volumes, commitments. For example, the Perkin Elmer partnership: "Perkin Elmer is a multi-billion dollar market leader... with customers in over 150 countries they make for a terrific partner to grow our ICP business." That is a partnership, but is it a commitment? They have a co-marketing agreement. They estimate 2019 revenues between several hundreds to several million dollars from market penetration. That is prospective. But the partnership itself is a commitment? The question asks about current activity, demand, or commitments arriving at a scale large relative to the company's small size. The company is small (Precipio is a small biotech). The Perkin Elmer partnership is a major industry player. That could be seen as a commitment that is large relative to the company's size. But does management convey that? They say "I cannot overestimate the importance of their selection of ICP as a complementary enrichment technology" - that is a validation. But is it a current business activity? They have a co-marketing agreement, so it's a commitment. However, the revenue estimate is for 2019, not current. The question asks about "business the company is doing RIGHT NOW" - so current activity, demand, commitments arriving at a scale large relative to the company's size. The Perkin Elmer partnership is a commitment, but it's not yet generating revenue. They say "The co-marketing agreement recently announced is the first step in building a strong ongoing relationship" - so it's a step, but not yet large revenue.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.